Becton Dickinson (BDX) Stock Price & AI Analysis

$172.27
$1.25
(0.73%)
Health Care Equipment

NYSE USA

May 16, 5:02 PM EDT
  • Market Cap.
    49.37B
  • Volume
    4.06M
  • Avg. Volume
    2.71M
  • Target Price
    $205.45
  • 52W Range
    163.33 - 251.99
  • RSI (14)
    33.52
  • Beta
    0.26
  • PEG Ratio
    4.55
  • SMA 20
    -6.68%
  • SMA 50
    -16.39%
  • SMA 200
    -23.93%
  • Insider Owner
    0.2%
  • Insider Trans
    -2.58%
  • Institution Owner
    92.52%
  • Institution Trans
    0.49%
  • Short Interest
    3.64%
  • EPS next Y
    4.26

Becton Dickinson Company Profile

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Becton Dickinson | Latest news

Becton, Dickinson and Company (NYSE:BDX) Receives $231.44 Average Price Target...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) has received an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, Marketbeat.com reports ...

ETF DAILY NEWS - 18 hours ago

UNH, TGT, BDX: 3 Ridiculously Undervalued Stocks Set to Surge in May 2025

The Federal Reserve seems well-positioned to do at least one rate cut this year. Companies managed...

247wallstcom - 2 days ago

BDX Q1 Earnings Call: Missed Revenue Expectations, Margin Expansion, and...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) missed Wall Street’s revenue...

StockStory - 2 days ago

BDx secures funding for Hong Kong data center

The data center will be located in Kwai Chung and is being designed in "close collaboration" with an unnamed anchor hyperscale data center. “This...

Data Center Dynamics - 4 days ago

Becton Dickinson (NYSE:BDX) Unveils Advanced Cell Analyzer With Spectral And...

Becton Dickinson (NYSE:BDX) gained attention this week with the global launch of its new cell...

Simply Wall St - 2 days ago

BDx secures financing for data centre expansion in Hong Kong

SINGAPORE (Reuters) -BDx Data Centers said on Tuesday that it has secured project financing from infrastructure credit firm Clifford Capital, Singapore's United Overseas Bank and Japan's Sumitomo ...

WSAU Wausau - 4 days ago

3 Dawdling Stocks with Questionable Fundamentals

To fully understand why you should be careful with ALG, check out our full research report (it’s free). BD (BDX) Rolling One-Year Beta: 0.33 With a...

StockStory - 2 days ago

Al Gore's Generation Investment Management Reduces Amazon Stake by 46.77%

Gore (Trades, Portfolio)'s portfolio included 38 stocks. The top holdings were 11.78% in Microsoft...

GuruFocuscom - 22 hours ago

Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?

Becton, Dickinson and Company BDX estimates a $90 million tariff expense for fiscal 2025 related to...

Zacks - 4 days ago

An Analysis of Becton Dickinson & Co

As a result of the transaction, Byrd Richard now holds 6,952 shares, worth roughly $1.16 million. Raymond James downgraded its Becton Dickinson & Co [BDX] rating to a Mkt perform from a an Outperform ...

Knox Daily - 5 days ago